Adcetris: Cure or Disease?

Patients and physicians show concern over the inaccurate warning labels and distribution of Adcetris, or Brentuximab vendotin. Adcetris, produced and manufactured by Seattle Genetics, helps to treat patients suffering from Hodgkin Lymphoma (HL) and Anaplastic Large Cell Lymphoma (ALCL) after an autologous stem cell transplant (ASCT) fails and after two multiagent chemotherapy regimens fail. Clinical case studies result in Adcetris’ ability to potentially treat Hodgkin lymphoma, but with serious side effects. Depending on the severity of the accident, an amputation may be partial or complete which affects the healing process and the ability to reattach the extremity to the body. A victim of a traumatic accident may have a partial amputation of any extremity, meaning part of the limb or extremity cannot be salvaged because of the accident. A complete amputation requires the entire removal of the injured area.

Adcetris is administered through intravenous infusion, or a solution containing the medication that is administered into a vein by a needle. The infusion occurs over a thirty minute time period every three weeks. A patient may have up to 16 cycles of Adcetris treatment in hopes of curing Hodgkin’s disease. As a serious drug, Adcetris has life threatening side effects that an individual may experience within 24 hours of the initial infusion.

Signs of reaction to Adcetris include:

Trouble breathing

Itching

Numbness

Chest pain or tightness

Side effects of Adcetris include, but are not limited to:

Dry Skin

Hair Loss

A change in mental state,

An inability to speak or see

Increases the risk of serious viral infection of the brain

Insomnia

Anxiety

Fever chills, weakness, tightness

Quickening or slowing of heart rates

Exhaustion

Nausea and Vomiting

Life Threatening Disabilities due to taking Adcetris:

PML – Progressive Multifocal Leukoencephalopathy

Pulmonary Toxicity

Peripheral Sensory Neuropathy

If you or a loved one experiences any of the above-listed side effects from Adcetris, please consult a physician immediately to prevent a worsening of symptoms. Because of such serious side effects, Adcetris was reevaluated by the U.S. Food and Drug Administration (FDA) who suggested caution when using Adcetris. Seattle Genetics manufacturing updated information as of January 2012 on the box labels, including warning and caution labels, contraindication, and dosage & administration. Patients and physicians should be warned about the potential serious side effects prior to using Adcetris.

The attorneys at Alvandi Law Group advocate for those who have been wrongfully harmed from the unexpected side effect of Adcetris – due to the improperly labeled safety labels and precautions. Call a Personal Injury and Pharmaceutical Attorney today for a free consultation pertaining to the facts of individual cases, and let a professional’s experience help you. For legal advice with no obligation, call at (800) 980-6905.